跳至主要内容
临床试验/NCT01070940
NCT01070940已完成1 期

L-NMMA's Effect on Renal and Cardiovascular Variables in Healthy Subjects. A Randomized, Placebo-controlled Crossover Study.

Regional Hospital Holstebro1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2010年2月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
12
试验地点
1
主要终点
Systolic blood pressure

研究概览

简要总结

The purpose of this study is to investigate the effect of different levels of nitric oxide inhibition on blood pressure and arterial stiffness in healthy subjects. L-NMMA, an inhibitor of the nitric oxide synthase, is administered as bolus injection followed by continuous infusion, and is expected to raise blood pressure and arterial stiffness according to L-NMMA dose.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 35 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Healthy males
  • Age 18-35 years
  • BMI 18.5-30.0

排除标准

  • Tobacco or illicit drug use
  • Current use of any prescription or non-prescription drugs
  • Alcohol abuse
  • History of heart failure, lever failure, chronic kidney disease or cerebral insult
  • Clinical or paraclinical signs of infection
  • Pathologic ECG
  • Ambulatory blood pressure >140/90 mmHg
  • Abnormal blood or urin screening tests

研究组 & 干预措施

Isotonic saline infusion

Placebo Comparator

干预措施: Placebo (Drug)

Intravenous L-NMMA dose 2

Active Comparator

干预措施: NG-monomethyl-L-arginine (L-NMMA) (Drug)

Intravenous L-NMMA dose 3

Active Comparator

干预措施: NG-monomethyl-L-arginine (L-NMMA) (Drug)

Intravenous L-NMMA dose 1

Active Comparator

干预措施: NG-monomethyl-L-arginine (L-NMMA) (Drug)

结局指标

主要结局

Systolic blood pressure

时间窗: 6 hours

次要结局

  • GFR(6 hours)
  • Arterial Stiffness(6 hours)
  • Fractional excretion of sodium(6 hours)
  • Fractional excretion of potassium(6 hours)
  • Plasma renin concentration(6 hour)
  • Plasma angiotensin II(6 hours)
  • Plasma aldosterone(6 hour)

研究者

发起方
Regional Hospital Holstebro
申办方类型
Other

研究点 (1)

Loading locations...

相似试验